These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9359070)

  • 41. [A case of malignant hyperthermia without hyperthermia].
    Muiños PA; Ortells MA; Sánchez G; Carrasco MS
    Rev Esp Anestesiol Reanim; 1995 Dec; 42(10):436. PubMed ID: 8789530
    [No Abstract]   [Full Text] [Related]  

  • 42. Suxamethonium-induced rhabdomyolysis in a healthy middle-aged man.
    Le Puura AI; Koivisto P; Annila P
    Acta Anaesthesiol Belg; 2000; 51(1):51-3. PubMed ID: 10806523
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Halothane and halothane/succinylcholine induced malignant hyperthermia (porcine stress syndrome) in a population of Ontario boars.
    Seeler DC; McDonell WN; Basrur PK
    Can J Comp Med; 1983 Jul; 47(3):284-90. PubMed ID: 6640412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sevoflurane as a potential replacement for halothane in diagnostic testing for malignant hyperthermia susceptibility: results of a preliminary study.
    Metterlein T; Hartung E; Schuster F; Roewer N; Anetseder M
    Minerva Anestesiol; 2011 Aug; 77(8):768-73. PubMed ID: 21730923
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of caffeine, halothane, succinylcholine, phenylephrine and isoproterenol on myocardial force of contraction of malignant hyperthermia susceptible swine.
    Scholz J; Roewer N; Rum U; Schmitz W; Scholz H; Schulte am Esch J
    Acta Anaesthesiol Scand; 1991 May; 35(4):320-5. PubMed ID: 1853693
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhalation anesthetics and Duchenne's muscular dystrophy.
    Goresky GV; Cox RG
    Can J Anaesth; 1999 Jun; 46(6):525-8. PubMed ID: 10391598
    [No Abstract]   [Full Text] [Related]  

  • 47. Xenon does not trigger malignant hyperthermia in susceptible swine.
    Froeba G; Marx T; Pazhur J; Baur C; Baeder S; Calzia E; Eichinger HM; Radermacher P; Georgieff M
    Anesthesiology; 1999 Oct; 91(4):1047-52. PubMed ID: 10519508
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of a commercial creatine kinase screening test for malignant hyperthermia (porcine stress syndrome).
    McDonell WN; Seeler DC; Basrur PK
    Can J Vet Res; 1986 Oct; 50(4):494-501. PubMed ID: 3791075
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Porcine malignant hyperthermia. I: Metabolic and physiological changes.
    Lucke JN; Hall GM; Lister D
    Br J Anaesth; 1976 Apr; 48(4):297-304. PubMed ID: 1275996
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients].
    Ben-Abraham R; Krivosic-Horber RM; Haudcoeur G; Perel A; Adnet PJ
    Harefuah; 1997 Jun; 132(12):839-41, 911. PubMed ID: 9264187
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Malignant hyperthermia: description and case report.
    Gohil P; Forman WM
    J Foot Surg; 1982; 21(1):7-11. PubMed ID: 7069146
    [No Abstract]   [Full Text] [Related]  

  • 52. Intramuscular injection of malignant hyperthermia trigger agents induces hypermetabolism in susceptible and nonsusceptible individuals.
    Metterlein T; Schuster F; Kranke P; Roewer N; Anetseder M
    Eur J Anaesthesiol; 2010 Jan; 27(1):77-82. PubMed ID: 19809329
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The dose-response relationship and regional distribution of lactate after intramuscular injection of halothane and caffeine in malignant hyperthermia-susceptible pigs.
    Schuster F; Schöll H; Hager M; Müller R; Roewer N; Anetseder M
    Anesth Analg; 2006 Feb; 102(2):468-72. PubMed ID: 16428544
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Anesthesia in hereditary peripheral muscular disease].
    Islander G; Jungner M
    Lakartidningen; 2005 Feb 21-27; 102(8):566-71. PubMed ID: 15786909
    [No Abstract]   [Full Text] [Related]  

  • 55. Malignant hyperthermia in the otology patient: the UCLA experience.
    Wackym PA; Blackwell KE
    Am J Otol; 1994 May; 15(3):371-5. PubMed ID: 8579142
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Duchenne muscular dystrophy: Which is the best anesthetic agent?
    Driessen J; Snoeck M
    Paediatr Anaesth; 2008 Oct; 18(10):1007-8. PubMed ID: 18811853
    [No Abstract]   [Full Text] [Related]  

  • 57. Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia.
    Ording H; Bendixen D
    Eur J Anaesthesiol; 1992 Sep; 9(5):367-76. PubMed ID: 1396623
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Malignant hyperthermia in a halothane-anesthetized horse.
    Waldron-Mease E; Klein LV; Rosenberg H; Leitch M
    J Am Vet Med Assoc; 1981 Nov; 179(9):896-8. PubMed ID: 7341603
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rapacuronium: an alternative to succinylcholine for electroconvulsive therapy.
    Kadar AG; Kramer BA; Barth MC; White PF
    Anesth Analg; 2001 May; 92(5):1171-2. PubMed ID: 11323342
    [No Abstract]   [Full Text] [Related]  

  • 60. An unusual case of malignant hyperthermia presenting on the acute medical take.
    Jones R; Shahid F; Cowell RP
    Br J Hosp Med (Lond); 2015 Feb; 76(2):110-1. PubMed ID: 25671478
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.